Visual Abstract

Background/Aims: Obesity is a known risk factor for cardiovascular disease and contributes to the development and progression of kidney disease. However, the specific influence of obesity on outcomes in primary glomerular disease has not been well characterized. Methods: In this prospective cohort study, data were from 541 participants enrolled in the Nephrotic Syndrome Study Network (NEPTUNE), between 2010 and 2019, at 23 sites across North America. Blood pressure, lipids, and kidney disease outcomes including complete proteinuria remission, kidney failure, and chronic kidney disease progression were evaluated. Data were analyzed using linear and logistic regression with generalized estimating equations and time-varying Cox regression with Kaplan-Meier plots. Results: The prevalence of obesity at baseline was 43.3% (N = 156) in adults and 37.6% (N = 68) in children. In adults, obesity was longitudinally associated with higher systolic BP (β = 6.49, 95% CI: 2.41, 10.56, p = 0.002), dyslipidemia (OR = 1.74, 95% CI: 1.30, 2.32, p < 0.001), triglycerides (β = 41.92, 95% CI: 17.12, 66.71, p = 0.001), and lower HDL (β = −6.92, 95% CI: −9.32, −4.51, p < 0.001). In children, obesity over time was associated with higher systolic BP index (β = 0.04, 95% CI: 0.02, 0.06, p < 0.001) and hypertension (OR = 1.43, 95% CI: 1.04, 1.98, p = 0.03). In both adults and children, obesity was associated with a significantly lower hazard of achieving complete remission of proteinuria (adult HR = 0.80, 95% CI: 0.69, 0.88, p < 0.001; pediatric HR = 0.72, 95% CI: 0.61, 0.84, p < 0.001). Conclusion: Obesity was associated with higher cardiovascular risk and less proteinuria remission from nephrotic syndrome in adults and children with proteinuric glomerulopathies. Weight-loss strategies may forestall cardiovascular disease and progressive kidney function decline in this high-risk patient group.

1.
Hales
CM
,
Carroll
MD
,
Fryar
CD
,
Ogden
CL
.
Prevalence of obesity among adults and youth: United States, 2015–2016
.
NCHS Data Brief
.
2017 Oct
;(
288
):
1
8
. ..
2.
Finkelstein
EA
,
Khavjou
OA
,
Thompson
H
,
Trogdon
JG
,
Pan
L
,
Sherry
B
, et al.
Obesity and severe obesity forecasts through 2030
.
Am J Prev Med
.
2012 Jun
;
42
(
6
):
563
70
. .
3.
Hruby
A
,
Hu
FB
.
The epidemiology of obesity: a big picture
.
Pharmacoeconomics
.
2015 Jul
;
33
(
7
):
673
89
. .
4.
Kovesdy
CP
,
Furth
SL
.
Zoccali
C
;
World Kidney Day Steering C
.
Obesity and kidney disease: hidden consequences of the epidemic
.
Clin Kidney J
.
2017 Feb
;
10
(
1
):
1
8
.
5.
Srivastava
T
,
Hariharan
S
,
Alon
US
,
McCarthy
ET
,
Sharma
R
,
El-Meanawy
A
, et al.
Hyperfiltration-mediated injury in the remaining kidney of a transplant donor
.
Transplantation
.
2018 Oct
;
102
(
10
):
1624
35
. .
6.
Kaur
K
,
Jun
D
,
Grodstein
E
,
Singer
P
,
Castellanos
L
,
Teperman
L
, et al.
Outcomes of underweight, overweight, and obese pediatric kidney transplant recipients
.
Pediatr Nephrol
.
2018 Dec
;
33
(
12
):
2353
62
. .
7.
Tsuboi
N
,
Utsunomiya
Y
,
Hosoya
T
.
Obesity-related glomerulopathy and the nephron complement
.
Nephrol Dial Transplant
.
2013 Nov
;
28
(
Suppl 4
):
iv108
13
. .
8.
D’Agati
VD
,
Chagnac
A
,
de Vries
AP
,
Levi
M
,
Porrini
E
,
Herman-Edelstein
M
, et al.
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
.
Nat Rev Nephrol
.
2016 Aug
;
12
(
8
):
453
71
. .
9.
Serra
A
,
Romero
R
,
Lopez
D
,
Navarro
M
,
Esteve
A
,
Perez
N
, et al.
Renal injury in the extremely obese patients with normal renal function
.
Kidney Int
.
2008 Apr
;
73
(
8
):
947
55
. .
10.
Wickman
C
,
Kramer
H
.
Obesity and kidney disease: potential mechanisms
.
Semin Nephrol
.
2013 Jan
;
33
(
1
):
14
22
. .
11.
Sumarac-Dumanovic
M
,
Gligic-Kuzmanovic
A
,
Stamenkovic-Pejkovic
D
,
Polovina
S
,
Jeremic
D
,
Cvijovic
G
, et al.
Association between obesity and glomerular hyperfiltration: impact on metabolic risk factors
.
Endocr Abstr
.
2017 May 3
;
49
:
EP694
. .
12.
Tobar
A
,
Ori
Y
,
Benchetrit
S
,
Milo
G
,
Herman-Edelstein
M
,
Zingerman
B
, et al.
Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria
.
PLoS One
.
2013
;
8
(
9
):
e75547
. .
13.
Camici
M
,
Galetta
F
,
Abraham
N
,
Carpi
A
.
Obesity-related glomerulopathy and podocyte injury: a mini review
.
Front Biosci
.
2012 Jan 1
;
4
:
1058
70
..
14.
Stenvinkel
P
,
Zoccali
C
,
Ikizler
TA
.
Obesity in CKD: What should nephrologists know?
J Am Soc Nephrol
.
2013
;
24
(
11
):
1727
36
. .
15.
Yonekura
Y
,
Goto
S
,
Sugiyama
H
,
Kitamura
H
,
Yokoyama
H
,
Nishi
S
.
The influences of larger physical constitutions including obesity on the amount of urine protein excretion in primary glomerulonephritis: research of the Japan Renal Biopsy Registry
.
Clin Exp Nephrol
.
2015 Jun
;
19
(
3
):
359
70
. .
16.
Elyan
BMP
,
Lees
JS
,
Gillis
KA
,
Mackinnon
B
,
Fox
JG
,
Geddes
CC
, et al.
Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases
.
BMC Nephrol
.
2019 Jul 2
;
20
(
1
):
237
. .
17.
Sethna
CB
,
Meyers
KEC
,
Mariani
LH
,
Psoter
KJ
,
Gadegbeku
CA
,
Gibson
KL
, et al.
Blood pressure and visit-to-visit blood pressure variability among individuals with primary proteinuric glomerulopathies
.
Hypertension
.
2017 Aug
;
70
(
2
):
315
23
. .
18.
Ashoor
IF
,
Mansfield
SA
,
O’Shaughnessy
MM
,
Parekh
RS
,
Zee
J
,
Vasylyeva
TL
, et al.
Prevalence of cardiovascular disease risk factors in childhood glomerular diseases
.
J Am Heart Assoc
.
2019
;
8
(
14
):
e012143
. .
19.
Sethna
CB
,
Ng
DK
,
Jiang
S
,
Saland
J
,
Warady
BA
,
Furth
S
, et al.
Cardiovascular disease risk among children with focal segmental glomerulosclerosis: a report from the chronic kidney disease in children study
.
Pediatr Nephrol
.
2019 Aug
;
34
(
8
):
1403
12
. .
20.
Gadegbeku
CA
,
Gipson
DS
,
Holzman
LB
,
Ojo
AO
,
Song
PX
,
Barisoni
L
, et al.
Design of the nephrotic syndrome study network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
.
Kidney Int
.
2013 Apr
;
83
(
4
):
749
56
. .
21.
Flynn
JT
,
Kaelber
DC
,
Baker-Smith
CM
,
Blowey
D
,
Carroll
AE
,
Daniels
SR
, et al.
Clinical practice guideline for screening and management of high blood pressure in children and adolescents
.
Pediatrics
.
2017 Sep
;
140
(
3
):
140
. .
22.
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents
.
Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report
.
Pediatrics
.
2011 Dec
;
128
(
Suppl 5
):
S213
56
. .
23.
Levey
AS
,
Stevens
LA
,
Schmid
CH
,
Zhang
YL
,
Castro
AF
 3rd
,
Feldman
HI
, et al.
A new equation to estimate glomerular filtration rate
.
Ann Intern Med
.
2009 May 5
;
150
(
9
):
604
12
. .
24.
Schwartz
GJ
,
Muñoz
A
,
Schneider
MF
,
Mak
RH
,
Kaskel
F
,
Warady
BA
, et al.
New equations to estimate GFR in children with CKD
.
J Am Soc Nephrol
.
2009 Mar
;
20
(
3
):
629
37
. .
25.
Ng
DK
,
Schwartz
GJ
,
Schneider
MF
,
Furth
SL
,
Warady
BA
.
Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease
.
Kidney Int
.
2018
;
94
(
1
):
170
7
. .
26.
Tsuboi
N
,
Okabayashi
Y
,
Shimizu
A
,
Yokoo
T
.
The renal pathology of obesity
.
Kidney Int Rep
.
2017 Mar
;
2
(
2
):
251
60
. .
27.
Herman-Edelstein
M
,
Scherzer
P
,
Tobar
A
,
Levi
M
,
Gafter
U
.
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
.
J Lipid Res
.
2014 Mar
;
55
(
3
):
561
72
. .
28.
Wu
Y
,
Liu
Z
,
Xiang
Z
,
Zeng
C
,
Chen
Z
,
Ma
X
, et al.
Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples
.
Endocrinology
.
2006 Jan
;
147
(
1
):
44
50
. .
29.
Carbone
S
,
Canada
JM
,
Billingsley
HE
,
Siddiqui
MS
,
Elagizi
A
,
Lavie
CJ
.
Obesity paradox in cardiovascular disease: Where do we stand?
Vasc Health Risk Manag
.
2019
;
15
:
89
100
. .
30.
Csige
I
,
Ujvárosy
D
,
Szabó
Z
,
Lőrincz
I
,
Paragh
G
,
Harangi
M
, et al.
The impact of obesity on the cardiovascular system
.
J Diabetes Res
.
2018
;
2018
:
3407306
. .
31.
Livingstone
DE
,
Jones
GC
,
Smith
K
,
Jamieson
PM
,
Andrew
R
,
Kenyon
CJ
, et al.
Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats
.
Endocrinology
.
2000 Feb
;
141
(
2
):
560
3
. .
32.
Goleva
E
,
Covar
R
,
Martin
RJ
,
Leung
DY
.
Corticosteroid pharmacokinetic abnormalities in overweight and obese corticosteroid resistant asthmatics
.
J Allergy Clin Immunol Pract
.
2016 Mar–Apr
;
4
(
2
):
357
e2
. .
33.
Sawamoto
K
,
Huong
TT
,
Sugimoto
N
,
Mizutani
Y
,
Sai
Y
,
Miyamoto
K
.
Mechanisms of lower maintenance dose of tacrolimus in obese patients
.
Drug Metab Pharmacokinet
.
2014
;
29
(
4
):
341
7
. .
34.
Henriques
VT
,
Martinez
EZ
,
Divino-Filho
JC
,
Pecoits-Filho
R
,
da Costa
JA
.
Increase in BMI over time is associated with fluid overload and signs of wasting in incident peritoneal dialysis patients
.
J Ren Nutr
.
2013 May
;
23
(
3
):
e51
7
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.